The effect of Chinese herbal medicine on albuminuria levels in patients with diabetic nephropathy: A systematic review and meta-analysis

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Xiao, Ya ^a   Liu, Yanyan ^a   Yu, Keqiang ^a   Zhou, Lin ^a   Bi, Jianlu ^a   Cheng, Jingru ^a   Li, Fei ^a   Luo, Ren ^a   Zhao, Xiaoshan ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BENAZEPRIL; CAPTOPRIL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; HERBACEOUS AGENT; IRBESARTAN; LOSARTAN; ORAL ANTIDIABETIC AGENT; PLACEBO; PROTEIN; TELMISARTAN; VALSARTAN;

ALBUMINURIA; ARTICLE; CHINESE MEDICINE; COCHRANE LIBRARY; CREATININE URINE LEVEL; DIABETIC NEPHROPATHY; DRUG CAPSULE; DRUG EFFICACY; DRUG SAFETY; HERBAL MEDICINE; HUMAN; MACROALBUMINURIA; MEDLINE; META ANALYSIS; MICROALBUMINURIA; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TABLET; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; URINARY EXCRETION;

EID: 84884240776     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/937549     Document Type: Article

References (50)

1. Ritz E., Rychlik I., Locatelli F., Halimi S., End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. American Journal of Kidney Diseases 1999 34 5 795 808 2-s2.0-0032737294
2. Ubink-Veltmaat L. J., Bilo H. J. G., Meyboom-de Jong B., Microalbuminuria in patients with type 2 diabetes mellitus in the general practice. Nederlands Tijdschrift voor Geneeskunde 2004 148 41 2026 2030 2-s2.0-5444258555
3. Scheffel R. S., Bortolanza D., Weber C. S., Costa L. A. D., Canani L. H., Santos K. G. D., Crispim D., Roisenberg I., Lisbôa H. R. K., Tres G. S., Tschiedel B., Gross J. L., Prevalence of micro and macroangiopatic chronic complications and their risk factors in the care of out patients with type 2 diabetes mellitus. Revista da Associacao Medica Brasileira 2004 50 3 263 267 2-s2.0-22044435128
4. Wu A. Y. T., Kong N. C. T., de Leon F. A., Pan C. Y., Tai T. Y., Yeung V. T. F., Yoo S. J., Rouillon A., Weir M. R., An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) study. Diabetologia 2005 48 1 17 26 2-s2.0-12944302104 10.1007/s00125-004-1599-9
5. Sasso F. C., Chiodini P., Carbonara O., High cardiovascular risk in patients with type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort study. Nephrology Dialysis Transplantation 2012 27 6 2269 2274
6. Gall M., Albuminuria in non-insulin-dependent diabetes mellitus: prevalence, causes, and consequences. Danish Medical Bulletin 1997 44 5 465 485 2-s2.0-0030656338
7. Ting R. Z. W., Luk A. O. Y., Chan J. C. N., Treatment and landmark clinical trials for renoprotection. Contributions to Nephrology 2011 170 184 195 2-s2.0-79959219097 10.1159/000325663
8. KDOQI, KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. American Journal of Kidney Diseases 2007 49 2 supplement 2 S12 S154
9. Luk A., Chan J. C. N., Diabetic nephropathy-what are the unmet needs? Diabetes Research and Clinical Practice 2008 82 supplement 1 S15 S20 2-s2.0-55249083701 10.1016/j.diabres.2008.09.033
10. Lai S. L., Hu J. Q., Guo X. F., Evidence-based medicine and clinical studies of traditional Chinese medicine. Journal of Guangzhou University of Chinese Medicine 2000 17 2 1 8
11. Lu J., He H., Clinical observation of Gingko biloba extract injection in treating early diabetic nephropathy. Chinese Journal of Integrative Medicine 2005 11 3 226 228 2-s2.0-26244438363
12. Ma S. T., Liu D. L., Niu R., Double-blind, randomized, placebo-controlled multi-centre phase: clinical trial of Arctiin granule in the treatment of diabetic nephropathy. The Chinese Journal of Clinical Pharmacology 2011 27 1 15 18
13. Chen W. Y., Clinical observation on Anshen yin treating 40 patients with diabetic nephropathy. Guiding Journal of the Traditional Chinese Medicine Pharmacy 2010 16 3 26 28
14. Xu Y., Effect of treatment with Baoshen tang in patients with early stage diabetic nephropathy. Liaoning Journal of the Traditional Chinese Medicine 2005 32 3 213
15. Luo H. Y., Clinical research of Bushen Huoxue prescription in the treatment of early stage diabetic nephropathy. Sciences, Technology and Engineering 2008 8 8 2176 2179
16. Huang Y. Q., Xu Y. S., Clinical observation on Bushen Huoxue Tongluo fang treating 38 patients with early stage diabetic nephropathy. Journal of the Traditional Chinese Medicine 2008 49 5 421 423
17. Ge Y. C., Xe H. L., Li S. J., Effect of tripterygium wilfordii in patients with diabetic nephropathy: a prospective randomized control clinical trial. Nephrology Dialysis Transplantation 2010 19 6 501 507
18. Xue J., Bai J. W., Effect of treatment with Liuwei Dihuang tang in 36 patients with early stage diabetic nephropathy. Journal of Practical Traditional Chinese Internal Medicine 2008 22 2 31
19. Zhang H. Q., Clinical observation on Pishen Shuangbu fang treating 38 patients with diabetic nephropathy. Guiding Journal of the Traditional Chinese Medicine Pharmacy 2012 18 2 38 40
20. Huang S. R., Clinical research of Shen an prescription in the treatment of early stage diabetic nephropathy. Journal of Changchun University of Traditional Chinese Medicine 2011 27 3 370 371
21. Zhang D. H., Wang K. F., Yang L. X., Clinical observation on Tangshen kang capsule treating 113 patients with diabetic nephropathy. Chinese Journal of Information on Traditional Chinese Medicine 2011 18 7 77 78
22. Huang S. R., Clinical research of Wenshen Jianpi Huoxue tang in the treatment of diabetic nephropathy. Journal of Liaoning Universtity of Traditional Chinese Medicine 2012 14 1 159 160
23. Dong Y. M., Li H. L., Ni Q., Clinical observation on Yiqi Huoxue fang treating 34 patients with early stage diabetic nephropathy. Journal of the New Chinese Medicine 2007 39 6 76 78
24. Zhou H., Shang X. Z., Xie P. F., Clinical research of Yiqi Yangyin Jiedu Tongluo tang in the treatment of early stage diabetic nephropathy. Tianjin Journal of Traditional Chinese Medicine 2009 26 2 100 102
25. Wang F. L., Chen Z. Q., Wang Y. H., Clinical research of Yiqi Yangyin Xiaozheng Tongluo tang in the treatment of early stage diabetic nephropathy. Chinese Journal of Integrated Traditional and Western Medicine 2012 1 35 38
26. Zhong L. N., Shen Y., Guan W., Kong F. F., Clinical observation on Ziyin Zhuyang Digui tang treating diabetic nephropathy in 50 patients with deficiency of kidney yin and yang syndrome. Beijing Journal of Traditional Chinese Medicine 2012 31 3 354 357
27. Chen Y. B., Wan Y. F., Effect of treatment with Qishen Yiqi drop pill in patients with type 2 early stage diabetic nephropathy. Chinese Journal of General Practice 2011 14 2 520 522
28. Wei J., Fang C. H., Peng D. Y., Chen Y., Zhu J. F., Gao X. K., Clinical observation on Fufang Danpi decoction treating diabetic nephropathy in patients with deficiency of qi and yin syndrome. China Pharmacy 2010 21 3 255 257
29. Feng T. B., Chen G. Y., Xie G. Q., Clinical research of Kangshen tang in the treatment of early stage diabetic nephropathy. Hubei Journal of Traditional Chinese Medicine 2005 27 9 17 19
30. Zhu X. L., Xu W. F., Ye M. H., Effect of treatment with Pingxiao Gujing tang in 22 patients with early stage diabetic nephropathy. Chinese Journal of Integrated Traditional and Western Nephrology 2004 5 3 156 157
31. Li J., He X., Li Q., Clinical study on treatment of early diabetic nephropathy by tangshenling combined with telmisartan. Chinese Journal of Integrated Traditional and Western Medicine 2006 26 5 415 418 2-s2.0-38049031716
32. Pan M. L., Xue F. M., Effect of treatment with Tangshen tang in patients with early stage diabetic nephropathy. Beijing Journal of Traditional Chinese Medicine 2009 28 4 289 290
33. Gong J. S., Wang H. T., Clinical research of Yangyin Yiqi decoction in the treatment of early stage diabetic nephropathy. Research Information of the Traditional Chinese Medicine 2004 6 8 18 19
34. Cai W., Lv Q., Han D., Effect of Yiqi Yangyin Huazhuo Tongluo recipe on plasma CTGF, type IV collagen and Cys C in patients with early stage diabetic nephropathy. Chinese Journal of Experimental Traditional Medical Formulae 2012 18 14 266 268
35. Qu Z. G., Effect of treatment with integrated traditional and western medicine in 36 patients with diabetic nephropathy. TCM Research 2012 25 7 19 21
36. Li B., Summarization on the combination of Chinese medicine and western medicine for the treatment of 20 cases of early stage diabetic nephropathy. Hunan Guiding Journal of the TCM 2004 10 7 16 17
37. Wu G. H., Zhang X. P., Effect of treatment with Integrated traditional and western medicine in 30 patients with early stage diabetic nephropathy. Guiding Journal of the TCM 2005 11 5 23 24
38. Chen X. Q., Huang Y. P., Clinical study on treatment of early diabetic nephropathy by self-composed Wuchong tang combined with Lotensin. Traditional Chinese Medicine Journal 2006 5 4 47 49
39. Fallahzadeh M. K., Dormanesh B., Sagheb M. M., Effect of addition of silymarin to renin-angiotensin system inhibitors on proteinuria in type 2 diabetic patients with overt nephropathy: a randomized, double-blind, placebo-controlled trial. American Journal of Kidney Diseases 2012 60 6 896 903
40. Khajehdehi P., Pakfetrat M., Javidnia K., Azad F., Malekmakan L., Nasab M. H., Dehghanzadeh G., Oral supplementation of turmeric attenuates proteinuria, transforming growth factor- β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study. Scandinavian Journal of Urology and Nephrology 2011 45 5 365 370 2-s2.0-80054052195 10.3109/00365599.2011.585622
41. Jadad A. R., Moore R. A., Carroll D., Jenkinson C., Reynolds D. J. M., Gavaghan D. J., McQuay H. J., Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials 1996 17 1 1 12 2-s2.0-0029914622 10.1016/0197-2456(95)00134-4
42. Liu X. P., Li J. P., Studies on pathologic evolution law of diabetes nephropathy. Chinese Journal of Chinese Medicine 2010 4 3 672 673
43. Navarro-González J. F., Mora-Fernández C., De Fuentes M. M., García-Pérez J., Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nature Reviews Nephrology 2011 7 6 327 340 2-s2.0-79957874666 10.1038/nrneph.2011.51
44. Singh D. K., Winocour P., Farrington K., Oxidative stress in early diabetic nephropathy: fueling the fire. Nature Reviews Endocrinology 2011 7 3 176 184 2-s2.0-79952186370 10.1038/nrendo.2010.212
45. Zhou X., Wang B., Zhu L., Hao S., A novel improved therapy strategy for diabetic nephropathy: targeting AGEs. Organogenesis 2012 8 1 18 21
46. Zhang Y., Wu C., Cheng J., Merit of astragalus polysaccharide in the improvement of early diabetic nephropathy with an effect on mRNA expressions of NF- B and I B in renal cortex of streptozotoxin-induced diabetic rats. Journal of Ethnopharmacology 2007 114 3 387 392 2-s2.0-35648986644 10.1016/j.jep.2007. 08.024
47. Yin X., Zhang Y., Yu J., Zhang P., Shen J., Qiu J., Wu H., Zhu X., The antioxidative effects of astragalus saponin I protect against development of early diabetic nephropathy. Journal of Pharmacological Sciences 2006 101 2 166 173 2-s2.0-33745305707 10.1254/jphs.FP0050041
48. Lee S., Kim Y., Lee S., Lee B., The protective effect of Salvia miltiorrhiza in an animal model of early experimentally induced diabetic nephropathy. Journal of Ethnopharmacology 2011 137 3 1409 1414 2-s2.0-80054878078 10.1016/j.jep.2011.08.007
49. Gao D., Li Q., Gao Z., Wang L., Antidiabetic effects of Corni fructus extract in streptozotocin-induced diabetic rats. Yonsei Medical Journal 2012 53 4 691 700
50. Schulz K. F., Altman D. G., Moher D., CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Journal of Pharmacology and Pharmacotherapeutics 2010 1 2 100 107